1 / 1

Muscle Invasive Bladder Cancer Market Insight, Epidemiology and Market Forecast 2030

Bladder cancer is the ninth most commonly diagnosed cancer worldwide, with more than 380,000 new cases each year and more than 150,000 deaths per year, and an estimated male-female ratio of 3.8:1.0.<br>In 2019, an estimated 80,470 adults (61,700 men and 18,770 women) in the United States had been diagnosed with bladder cancer.<br>Bladder cancer mostly affects older people. Ninety per cent (90%) of people with bladder cancer are older than 55, and the average age of people diagnosed with bladder cancer is around 73 years.<br><br>To read more visit: https://www.delveinsight.com/report-store/muscle-invasive-bladder-cancer-market<br>#Urology #bladdercancer #cancer<br>

arawat
Télécharger la présentation

Muscle Invasive Bladder Cancer Market Insight, Epidemiology and Market Forecast 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Muscle Invasive Bladder Cancer Market Insight, Epidemiology and Market Forecast 2030 Muscle Invasive Bladder Cancer market key facts ● Bladder cancer is the ninth most commonly diagnosed cancer worldwide, every year more than 380,000 new cases and more than 150,000 deaths are registered due to bladder cancer. ● The male to female ratio for bladder cancer is around 3.8:1.0. ● Around 80,470 adults (which comprises 61,700 men and 18,770 women) are diagnosed with bladder cancer in the United States in 2019. ● About 90% of people with bladder cancer are older than 55. 73 years is the average of people diagnosed with bladder cancer. Muscle Invasive Bladder Cancer report key benefit ● Delveinsight Muscle Invasive Bladder Cancer market report provides in-depth analysis and comprehensive insight of the Muscle Invasive Bladder Cancer market epidemiology and market forecast in the 7 Major Markets (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.) ● The report provides a detailed overview of Muscle Invasive Bladder Cancer current and emerging therapies . ● Muscle Invasive Bladder Cancer market report covers the historical and forecasted market analysis of Muscle Invasive Bladder Cancer. ● The DelveInsight Muscle Invasive Bladder cancer market report gives a thorough understanding of the Muscle Invasive Bladder cancer market such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. ● Muscle Invasive Bladder cancer report encloses the detailed analysis of Muscle Invasive Bladder cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs . ● It also analyses Muscle Invasive Bladder cancer key players involved in developing targeted therapeutics. Some of the key market players in Muscle Invasive Bladder Cancer market includes Merck Bristol-Myers Squibb, Sharp & Dohme and AstraZeneca ● Some of the emerging therapies in the Muscle Invasive Bladder Cancer market includes Durvalumab, Pembrolizumab, Nivolumab. Muscle Invasive Bladder Cancer market is expected to significantly impact the Muscle Invasive Bladder Cancer treatment scenario in the upcoming years. About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

More Related